Advertisement
Screener

Nuvation Bio Inc. (NUVB) ROE

Nuvation Bio Inc. (NUVB) ROE

  • 2026-06-30: ROE -59.02%.
  • 2026-03-31: ROE -45.69%.
  • 2025-12-31: ROE -66.93%.
  • 2025-09-30: ROE -66.74%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-59.02%
2026-03-31-45.69%
2025-12-31-66.93%
2025-09-30-66.74%
2025-06-30-54.41%
2025-03-31-144.56%
2024-12-31-122.46%
2024-09-30-105.88%
2024-06-30-198.57%
2024-03-31-11.59%
2023-12-31-12.53%
2023-09-30-13.55%
2023-06-30-14.47%
2023-03-31-16.32%
2022-12-31-15.91%
2022-09-30-16.24%
2022-06-30-14.90%
2022-03-31-12.13%
2021-12-31-11.64%
2021-09-30-9.75%
2021-06-30-8.12%
2021-03-31-6.61%
2020-12-31-19.37%

Annual ROE

DateROE
2025-12-31-66.93%
2024-12-31-122.46%
2023-12-31-12.53%
2022-12-31-15.91%
2021-12-31-11.64%
2020-12-31-19.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B